今日药学

2006, (04) 67-69

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Archive) | 高级检索(Advanced Search)

治疗前列腺增生症药物的临床应用分析
Analysis of the drugs used for benign prostatic hyperplasia in Gongbei hospital of ZhuHai City in three years

杨潜
YANG Qian(Gongbei Hospital of ZhuHai City

摘要(Abstract):

目的分析治疗前列腺增生症药物的临床应用情况。方法统计珠海市拱北医院2002-2004年治疗前列腺增生症药物的品种、用量、金额、DDD s以及临床应用评价。结果3年来我院治疗前列腺增生症药物品种变化不大,但总的用量有所上升。用量最大的药物为非那甾胺、特拉唑嗪和坦索罗辛等。结论治疗前列腺增生症药物已成为社会需求量较大的一类常用药物,价格亦较贵,有待国产化,以满足患者的用药需求。
Objective To analyze the usage of drugs for therapy benign prostatic hyperplasia(BHP) in my hospital.Methods The BHP drugs used in Gongbei hospital of Zhuhai city during the 2002-2004 period in respect to the amount of consumption,kinds,sum of money of consumption,DDDs and clinical evaluation were investigated.Results Consumption of BPH drugs was increasing in recent years,the major drugs for BPH were Finasteride,Terazosin and Tamsulosin,ect.Conclusion The BPH drugs are common drugs,but price is expensive.

关键词(KeyWords): 治疗前列腺增生症药物;临床应用;分析
therapeutic drugs for benign prostatic hyperplasia;clinical use;analysis

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 杨潜
YANG Qian(Gongbei Hospital of ZhuHai City

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享